MyAverix Finance
US · Healthcare
Radiopharm Theranostics Limited American Depositary Shares (RADX)
Biotechnology
Radiopharm Theranostics Limited American Depositary Shares (RADX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RADX
Radiopharm Theranostics Limited American Depositary Shares (RADX) — FAQ
What is RADX's P/E ratio?
The price-to-earnings (P/E) ratio for Radiopharm Theranostics Limited American Depositary Shares (RADX) is 25.00 (data as of 2026-05-23).
Does Radiopharm Theranostics Limited American Depositary Shares pay a dividend?
Dividend yield is not available in the current snapshot for Radiopharm Theranostics Limited American Depositary Shares (RADX). Check the MyAverix Finance app for the latest dividend data.
What sector is Radiopharm Theranostics Limited American Depositary Shares in?
Radiopharm Theranostics Limited American Depositary Shares (RADX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is RADX listed on?
RADX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.